weight loss, Drug

England subsidises drugs like Ozempic for weight loss. Could Australia follow?
People with a high body weight living in England can now access subsidised weight-loss drugs to treat their obesity.
Weight-loss drugs aren’t just slimming waists. They’re shifting the economy.
Ozempic, Mounjaro and Wegovy may not be the lightbulb, jet airplane or internet, but their impact is expected to be so significant it could shift GDP.
Drug compounders sue over weight loss drugs’ removal from FDA shortage list
A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for removing semaglutide, the active ingredient in Ozempic, from its drug
Is Ozempic safe for weight loss? What doctors want you to know about blockbuster drug
Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 drugs, and whether they're safe.
Weight-Loss Drugs Like Ozempic Can Help Alcohol Addiction
Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA Psychiatry, researchers report that semaglutide, better known as Ozempic or Wegovy, helped people with alcohol addiction reduce their craving and drink less.
Yearslong shortage of popular weight-loss and diabetes drugs resolved, FDA says
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of obesity treatments improve.
England subsidizes drugs like Ozempic for weight loss. Could Australia follow?
People with a high body weight living in England can now access subsidized weight-loss drugs to treat their obesity. This includes Wegovy (the weight-loss dose of Ozempic, or semaglutide) and Mounjaro (one of the brand names for tirzepatide).
Oklahoma AG urges FDA to combat influx of counterfeit weight-loss drugs
Oklahoma Attorney General Gentner Drummond called on the FDA to take action against counterfeit weight-loss drug makers.Genter and 37 other attorney generals wr
Off-brand weight-loss drug makers are suing the FDA, again
A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another lawsuit against the U.S. Food and Drug Administration (FDA). This time, it’s over the health regulator’s decision to remove semaglutide — the active ingredient in Novo Nordisk’s (NVO) popular Ozempic and Wegovy treatments — from its drug shortage list.
These people are all taking Ozempic in secret — the real reasons no one wants to ‘fess up
“As time goes on, they’re more willing to share their story because they get so many compliments,” she said. “The person who is next to them says, ‘Tell me your secret,’ and they may whisper my name ...
Hims is officially phasing out its copycat weight-loss drugs, and the company's stock tumbled — again
After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...
Channel 4 News1d
Should we be worried about deaths linked to weight loss jabs including Ozempic?
Medical treatments, including jabs used for weight loss, are monitored in part using the Medicines and Healthcare products ...
NOLA.com1d
Weight loss drugs are silencing ‘food noise.’ Louisiana researchers are taking note.
Patients report that GLP-1 drugs like Ozempic and Mounjaro reduce “food noise,” the constant mental chatter about eating.
Novo Nordisk Stock Rallies on Weight-Loss Retreat by Hims & Hers
Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to ...
Hollywood’s Ozempic craze has ‘changed the narrative’ of body positivity as celebs are noticeably slimmer than ever
Weight loss drugs quickly became the go-to tactic for celebrities like Fat Joe, Kathy Bates, Macy Gray, Kelly Clarkson, Rebel ...
Hosted on MSN6h
The Scary Ozempic Side Effect No One's Talking About—and What You Can Do
Ozempic is often hailed as a wonder drug, but like any other medication, it’s not perfect. People have reported mild side ...